{
  "meta": {
    "title": "Anemia: Approach to anemia",
    "url": "https://brainandscalpel.vercel.app/anemia-approach-to-anemia-17d44b3a-167143.html",
    "scrapedAt": "2025-12-01T04:54:56.371Z",
    "type": "article"
  },
  "content": "\n                <div><h1>Introduction</h1>\n<p>Anemia is characterized by a decrease in hematocrit (a marker of red blood cell [RBC] mass) and/or hemoglobin concentration, potentially leading to impaired oxygen delivery to tissue.&nbsp; It can arise from a variety of causes, broadly grouped into 3 mechanisms: blood loss, impaired RBC production, and increased RBC destruction.&nbsp; The evaluation of anemia involves integrating clinical presentation with targeted laboratory investigations to identify the underlying cause.</p>\n<h1>RBC homeostasis</h1><h2>Erythropoiesis</h2><br><br><p>Erythropoietin (EPO), which is secreted by the kidneys in response to tissue hypoxia (\n                                </p><div class=\"my-8\">\n                                    <img src=\"https://www.uworld.com/media/L94613.png\" alt=\"figure 1\" class=\"w-full rounded-lg border border-white border-opacity-20 shadow-lg\">\n                                    <div class=\"text-sm text-center text-white text-opacity-60 mt-2 italic\">figure 1</div>\n                                </div>\n                                ), stimulates hematopoietic stem cells in the bone marrow to undergo differentiation, rapid replication, and division.&nbsp; This process eventually results in the production of reticulocytes (immature RBCs), which exit the bone marrow and eventually become mature RBCs.&nbsp; Normal RBCs are anucleate and have a biconcave disc shape with a central pallor.<p></p>\n<h2>Hemoglobin and iron</h2><br><br><p>Hemoglobin, the major protein in RBCs, consists of 4 globin subunits (2 alpha-globin and 2 beta-globin subunits) (\n                                </p><div class=\"my-8\">\n                                    <img src=\"https://www.uworld.com/media/L38416.jpg\" alt=\"figure 2\" class=\"w-full rounded-lg border border-white border-opacity-20 shadow-lg\">\n                                    <div class=\"text-sm text-center text-white text-opacity-60 mt-2 italic\">figure 2</div>\n                                </div>\n                                ).&nbsp; Each globin chain has an iron-containing heme group that can reversibly bind to oxygen.&nbsp; Fully saturated hemoglobin (oxyhemoglobin) is bound to 4 oxygen molecules.<p></p><br><br><p>Recycling of damaged and aged RBCs (and iron) primarily occurs within the reticuloendothelial system (RES, also known as the mononuclear phagocyte system), consisting of macrophages, monocytes, and reticular cells in the spleen, liver (known as Kupffer cells) and elsewhere (eg, alveoli).</p><br><br><p>Key proteins involved in iron homeostasis include the following:</p><br><br><ul class=\"article-body-unordered-list\">\n\t<li><strong>Transferrin</strong> transports circulating iron; due to negative feedback regulation, transferrin levels (also sometimes reported as total iron-binding capacity [TIBC]) decrease when iron levels are abundant.&nbsp; Transferrin saturation (ratio of serum iron to TIBC) is the percentage of iron bound to transferrin and is directly proportional to the level of iron.</li>\n\t<li><strong>Ferritin</strong> serves as an iron storage protein; it increases in proportion to total iron stores but also can be elevated as an acute phase reactant (independent of iron levels) in states of inflammation, infection, malignancy.</li>\n\t<li><strong>Hepcidin</strong> regulates iron bioavailability and is produced by the liver (\n                                <div class=\"my-8\">\n                                    <img src=\"https://www.uworld.com/media/L18386.png\" alt=\"figure 3\" class=\"w-full rounded-lg border border-white border-opacity-20 shadow-lg\">\n                                    <div class=\"text-sm text-center text-white text-opacity-60 mt-2 italic\">figure 3</div>\n                                </div>\n                                ).&nbsp; Increased hepcidin levels, seen in states of inflammation or infection, decrease iron bioavailability by reducing intestinal absorption of iron and release from macrophages.</li>\n</ul>\n<h1>Complete blood count and hemoglobin parameters</h1><br><br><p>Anemia is diagnosed with complete blood count (CBC).&nbsp; General definitions of anemia include the following:</p><br><br><ul class=\"article-body-unordered-list\">\n\t<li><strong>Hemoglobin</strong> &lt;11.5 g/dL (females) or &lt;13.5 g/dL (males)</li>\n\t<li><strong>Hematocrit</strong> &lt;35% (females) or &lt;40% (males)</li>\n</ul><br><br><p>In children, anemia is typically defined by a hemoglobin or hematocrit â‰¤2.5th percentile.</p><br><br><p>Other parameters of RBC health reported with CBC include the following:</p><br><br><ul class=\"article-body-unordered-list\">\n\t<li><strong>Mean corpuscular volume (MCV)</strong> depicts RBC size; abnormalities include microcytosis (small size, &lt;80 Î¼m<font size=\"2\"><sup>3</sup></font>), macrocytosis (large size, &gt;100 Î¼m<font size=\"2\"><sup>3</sup></font>).</li>\n\t<li><strong>Red cell distribution width (RDW)</strong> is a marker of RBC size variability; abnormalities include anisocytosis (increased RDW).</li>\n\t<li><strong>Mean corpuscular hemoglobin concentration (MCHC) and mean corpuscular hemoglobin (MCH)</strong> depict average RBC hemoglobin concentration and content; abnormalities include hypochromia (low MCHC/MCH).</li>\n</ul><br><br><p>A peripheral smear test enables direct visualization of RBCs (\n                                </p><div class=\"my-8\">\n                                    <img src=\"https://www.uworld.com/media/L22800.png\" alt=\"image 1\" class=\"w-full rounded-lg border border-white border-opacity-20 shadow-lg\">\n                                    <div class=\"text-sm text-center text-white text-opacity-60 mt-2 italic\">image 1</div>\n                                </div>\n                                ), assessing for color (eg, hypochromia), abnormally shaped cells (eg, sickle-shaped, spherocytes), evidence of trauma (eg, schistocytes), or malformed cells (eg, target cells).&nbsp; Reticulocytes, which are larger than RBCs and have a blue tint (polychromatophilia (\n                                <div class=\"my-8\">\n                                    <img src=\"https://www.uworld.com/media/L69458.jpg\" alt=\"image 2\" class=\"w-full rounded-lg border border-white border-opacity-20 shadow-lg\">\n                                    <div class=\"text-sm text-center text-white text-opacity-60 mt-2 italic\">image 2</div>\n                                </div>\n                                )), can also be seen on a peripheral blood smear (normally 1%-2% of circulating RBCs).<p></p><br><br><p>The significance of abnormalities in hemoglobin parameters is discussed further below.</p>\n<h1>Conceptual approach to anemia</h1><br><br><p>Anemia can be classified into 3 main categories based on the underlying pathophysiology:</p><br><br><ul class=\"article-body-unordered-list\">\n\t<li><strong>Blood loss</strong>, whether acute or chronic, directly decreases blood volume and leads to iron deficiency.</li>\n\t<li><strong>Inadequate RBC production</strong> may occur due to nutritional deficiencies, bone marrow failure, or states of chronic inflammation, all of which impair erythropoiesis.</li>\n\t<li><strong>Increased RBC destruction (hemolysis)</strong> may occur due to intrinsic defects in the structure or shape of RBC, or external (eg, immune-mediated) destruction.</li>\n</ul><br><br><p>Understanding this conceptual framework helps guide the diagnostic process and refine further testing.</p>\n<h1>Blood loss</h1><br><br><p>Blood loss may be acute or chronic.</p>\n<h2>Acute blood loss</h2><br><br><p>Associated with precipitating factors (eg, surgery, trauma), acute blood loss manifests with acute clinical signs (eg, tachycardia, hypotension) and symptoms (eg, melena, abdominal pain from gastrointestinal bleeding).&nbsp; In acute blood loss, the hemoglobin and hematocrit initially remain normal within the first 36-48 hours.</p>\n<h2>Chronic blood loss</h2><br><br><p>Chronic blood loss progressively depletes iron stores and results in iron deficiency anemia (IDA); it is commonly caused by occult gastrointestinal bleeding (eg, peptic ulcers, colorectal cancer) and menorrhagia.&nbsp; Due to chronicity, patients are often asymptomatic or have mild, nonspecific symptoms (eg, fatigue); more pronounced symptoms may be present in later stages (eg, dyspnea on exertion, pallor).</p>\n<h1>Inadequate RBC production</h1><br><br><p>Causes of inadequate RBC production include deficiencies in nutrients necessary for erythropoiesis (eg, iron, B<font size=\"2\"><sub>12</sub></font>) and conditions affecting the bone marrow (eg, malignancy).</p>\n<h2>Nutritional deficiencies</h2><br><br><p>Common nutritional deficiencies associated with anemia include iron, vitamin B<font size=\"2\"><sub>12</sub></font> (\n                                </p><div class=\"my-6\">\n                                    <a href=\"https://www.uworld.com/media/116692.html\" target=\"_blank\" class=\"glass-button w-full py-4 flex items-center justify-center text-white font-bold hover:scale-[1.02] transition-transform\">\n                                        <span class=\"mr-2\">ðŸ“Š</span> View Table: table 1\n                                    </a>\n                                </div>\n                                ), folate, and copper.&nbsp; Nutritional deficiencies may result from deficient dietary intake (eg, strict, unsupplemented vegan diet low in iron or B<font size=\"2\"><sub>12</sub></font>; however, folate deficiency through diet is very rare in the absence of excess alcohol use) and gut malabsorption (eg, gastric bypass surgery (\n                                <div class=\"my-6\">\n                                    <a href=\"https://www.uworld.com/media/97502.html\" target=\"_blank\" class=\"glass-button w-full py-4 flex items-center justify-center text-white font-bold hover:scale-[1.02] transition-transform\">\n                                        <span class=\"mr-2\">ðŸ“Š</span> View Table: table 2\n                                    </a>\n                                </div>\n                                ), celiac disease, Crohn disease).&nbsp; In children, exclusive breastfeeding after age 6 months and early introduction of cow's milk (age &lt;1) and/or drinking &gt;24 oz (700 mL) cow's milk per day are risk factors for IDA (\n                                <div class=\"my-6\">\n                                    <a href=\"https://www.uworld.com/media/38195.html\" target=\"_blank\" class=\"glass-button w-full py-4 flex items-center justify-center text-white font-bold hover:scale-[1.02] transition-transform\">\n                                        <span class=\"mr-2\">ðŸ“Š</span> View Table: table 3\n                                    </a>\n                                </div>\n                                ).&nbsp; Additional causes include the following:<p></p><br><br><ul class=\"article-body-unordered-list\">\n\t<li><strong>Iron:</strong>&nbsp; chronic blood loss, including gastrointestinal or menstrual bleeding</li>\n\t<li><strong>Vitamin B</strong><font size=\"2\"><sub><strong>12</strong></sub></font><strong>:</strong>&nbsp; impaired hydrochloric acid and intrinsic factor secretion by parietal cells (\n                                <div class=\"my-8\">\n                                    <img src=\"https://www.uworld.com/media/L24633.jpg\" alt=\"image 3\" class=\"w-full rounded-lg border border-white border-opacity-20 shadow-lg\">\n                                    <div class=\"text-sm text-center text-white text-opacity-60 mt-2 italic\">image 3</div>\n                                </div>\n                                ) (eg, atrophic gastritis, pernicious anemia), or medications interfering with acid secretion or vitamin B<font size=\"2\"><sub>12</sub></font> absorption (eg, proton pump inhibitors, metformin)</li>\n\t<li><strong>Copper:</strong>&nbsp; excess zinc administration</li>\n</ul><br><br><p>Patients may have nonspecific signs of chronic anemia, including decreased exercise tolerance, fatigue, and dyspnea on exertion.&nbsp; Additional symptoms unique for each deficiency include the following:</p><br><br><ul class=\"article-body-unordered-list\">\n\t<li><strong>Iron</strong> (\n                                <div class=\"my-6\">\n                                    <a href=\"https://www.uworld.com/media/84123.html\" target=\"_blank\" class=\"glass-button w-full py-4 flex items-center justify-center text-white font-bold hover:scale-[1.02] transition-transform\">\n                                        <span class=\"mr-2\">ðŸ“Š</span> View Table: table 4\n                                    </a>\n                                </div>\n                                ):&nbsp; pica (compulsive consumption of nonfood substances, typically ice), nail changes (eg, spoon-shaped nails), and glossitis (smooth tongue)</li>\n\t<li><strong>Vitamin B</strong><font size=\"2\"><sub><strong>12</strong></sub></font><strong>:</strong>&nbsp; paresthesia, impaired proprioception, neuropathy, cognitive decline; neurologic symptoms may be less prominent in folate deficiency</li>\n\t<li><strong>Copper:</strong>&nbsp; skin depigmentation, hepatosplenomegaly, osteoporosis</li>\n</ul><br><br><p>Laboratory findings associated with each nutritional deficiency include the following:</p><br><br><ul class=\"article-body-unordered-list\">\n\t<li><strong>Iron deficiency:</strong>&nbsp; Laboratory anomalies depend on the stage of IDA (\n                                <div class=\"my-8\">\n                                    <img src=\"https://www.uworld.com/media/L80214.png\" alt=\"figure 4\" class=\"w-full rounded-lg border border-white border-opacity-20 shadow-lg\">\n                                    <div class=\"text-sm text-center text-white text-opacity-60 mt-2 italic\">figure 4</div>\n                                </div>\n                                ).&nbsp; Low ferritin is the earliest (most sensitive) indicator of decreased iron storage; at this stage, serum iron and MCV are normal, and reticulocyte production increases to compensate.&nbsp; As IDA progresses, serum iron decreases; at this stage, an increase in iron binding capacity (transferrin levels) and decreased transferrin saturation are seen.&nbsp; In late-stage IDA (typically hemoglobin &lt;10 g/dL), the reticulocyte count decreases due to insufficient iron, and microcytosis (low MCV) and low MCHC (hypochromia) occur (\n                                <div class=\"my-8\">\n                                    <img src=\"https://www.uworld.com/media/L74138.jpg\" alt=\"image 4\" class=\"w-full rounded-lg border border-white border-opacity-20 shadow-lg\">\n                                    <div class=\"text-sm text-center text-white text-opacity-60 mt-2 italic\">image 4</div>\n                                </div>\n                                ).</li>\n\t<li><strong>Vitamin B</strong><font size=\"2\"><sub><strong>12</strong></sub></font> <strong>deficiency and folate anemia:</strong>&nbsp; Laboratory anomalies include megaloblastic anemia (\n                                <div class=\"my-8\">\n                                    <img src=\"https://www.uworld.com/media/L65104.png\" alt=\"Megaloblastic anemia\" class=\"w-full rounded-lg border border-white border-opacity-20 shadow-lg\">\n                                    <div class=\"text-sm text-center text-white text-opacity-60 mt-2 italic\">Megaloblastic anemia</div>\n                                </div>\n                                ), manifesting as macrocytic RBCs with hypersegmented neutrophils (\n                                <div class=\"my-8\">\n                                    <img src=\"https://www.uworld.com/media/L19280.jpg\" alt=\"image 6\" class=\"w-full rounded-lg border border-white border-opacity-20 shadow-lg\">\n                                    <div class=\"text-sm text-center text-white text-opacity-60 mt-2 italic\">image 6</div>\n                                </div>\n                                ) on peripheral smear, and a low reticulocyte count.&nbsp; Homocysteine and methylmalonic acid (MMA) are also elevated in vitamin B<font size=\"2\"><sub>12</sub></font> deficiency; MMA is not typically elevated in folate deficiency (\n                                <div class=\"my-8\">\n                                    <img src=\"https://www.uworld.com/media/L24626.jpg\" alt=\"figure 5\" class=\"w-full rounded-lg border border-white border-opacity-20 shadow-lg\">\n                                    <div class=\"text-sm text-center text-white text-opacity-60 mt-2 italic\">figure 5</div>\n                                </div>\n                                ).</li>\n\t<li><strong>Copper:</strong>&nbsp; Microcytic anemia (due to impairment of iron absorption), although normocytic anemia is also common.&nbsp; Leukopenia may be seen.</li>\n</ul>\n<h2>Bone marrow failure</h2><br><br><ul class=\"article-body-unordered-list\">\n\t<li><strong>Aplastic anemia</strong> (\n                                <div class=\"my-6\">\n                                    <a href=\"https://www.uworld.com/media/42378.html\" target=\"_blank\" class=\"glass-button w-full py-4 flex items-center justify-center text-white font-bold hover:scale-[1.02] transition-transform\">\n                                        <span class=\"mr-2\">ðŸ“Š</span> View Table: table 5\n                                    </a>\n                                </div>\n                                ) results from bone marrow suppression, either due to destruction or deficiency of hematopoietic stem cells; it manifests with pancytopenia (eg, leukopenia, thrombocytopenia, anemia) with a low reticulocyte count.&nbsp; Bone marrow biopsy reveals a hypocellular marrow.&nbsp; Aplastic anemia may be idiopathic, drug-induced (eg, radiation, chemotherapy, antiseizure medications), postinfectious (eg, Epstein-Barr virus, hepatitis, HIV), or congenital (eg, Fanconi anemia, an autosomal recessive condition presenting in childhood) (\n                                <div class=\"my-6\">\n                                    <a href=\"https://www.uworld.com/media/42302.html\" target=\"_blank\" class=\"glass-button w-full py-4 flex items-center justify-center text-white font-bold hover:scale-[1.02] transition-transform\">\n                                        <span class=\"mr-2\">ðŸ“Š</span> View Table: table 6\n                                    </a>\n                                </div>\n                                ).</li>\n\t<li><strong>Myelodysplastic syndromes (MDS)</strong> (\n                                <div class=\"my-6\">\n                                    <a href=\"https://www.uworld.com/media/31231.html\" target=\"_blank\" class=\"glass-button w-full py-4 flex items-center justify-center text-white font-bold hover:scale-[1.02] transition-transform\">\n                                        <span class=\"mr-2\">ðŸ“Š</span> View Table: table 7\n                                    </a>\n                                </div>\n                                ) is a neoplastic disorder characterized by an abundance of ineffective, dysplastic hematopoietic stem cells.&nbsp; Similar to aplastic anemia, MDS causes normocytic or macrocytic anemia along with other cytopenias; however, the bone marrow shows hypercellularity with dysplastic cells.&nbsp; The peripheral smear also reveals dysplastic RBCs (eg, oval macrocytes) and leukocytes, including granulocytes, which are hyposegmented (\n                                <div class=\"my-8\">\n                                    <img src=\"https://www.uworld.com/media/L23288.png\" alt=\"image 7\" class=\"w-full rounded-lg border border-white border-opacity-20 shadow-lg\">\n                                    <div class=\"text-sm text-center text-white text-opacity-60 mt-2 italic\">image 7</div>\n                                </div>\n                                ) and hypogranulated (\n                                <div class=\"my-8\">\n                                    <img src=\"https://www.uworld.com/media/L20905.png\" alt=\"image 8\" class=\"w-full rounded-lg border border-white border-opacity-20 shadow-lg\">\n                                    <div class=\"text-sm text-center text-white text-opacity-60 mt-2 italic\">image 8</div>\n                                </div>\n                                ).&nbsp; Patients are often asymptomatic or may have mild, nonspecific symptoms (eg, fatigue, pallor).</li>\n</ul>\n<h2>Chronic disease and inflammation</h2><br><br><p>Anemia of chronic disease (ACD) (\n                                </p><div class=\"my-6\">\n                                    <a href=\"https://www.uworld.com/media/60023.html\" target=\"_blank\" class=\"glass-button w-full py-4 flex items-center justify-center text-white font-bold hover:scale-[1.02] transition-transform\">\n                                        <span class=\"mr-2\">ðŸ“Š</span> View Table: table 8\n                                    </a>\n                                </div>\n                                ) is seen in states of chronic inflammation, such as autoimmune disease or chronic kidney disease (which is associated with a multifactorial anemia, including IDA) (\n                                <div class=\"my-8\">\n                                    <img src=\"https://www.uworld.com/media/L80500.png\" alt=\"figure 6\" class=\"w-full rounded-lg border border-white border-opacity-20 shadow-lg\">\n                                    <div class=\"text-sm text-center text-white text-opacity-60 mt-2 italic\">figure 6</div>\n                                </div>\n                                ).&nbsp; ACD can be thought of as functional iron deficiency (\n                                <div class=\"my-6\">\n                                    <a href=\"https://www.uworld.com/media/80731.html\" target=\"_blank\" class=\"glass-button w-full py-4 flex items-center justify-center text-white font-bold hover:scale-[1.02] transition-transform\">\n                                        <span class=\"mr-2\">ðŸ“Š</span> View Table: Iron deficiency anemia  thalassemias\n                                    </a>\n                                </div>\n                                ).&nbsp; Bone marrow iron stores are normal or high, but iron bioavailability is decreased due to cytokines (IL-6, tumor necrosis factor-alpha) that increase hepcidin and suppress transferrin production; this promotes iron sequestration within the RES, with lower TIBC and circulating iron levels.&nbsp; As a result, the reticulocyte count is low (or inappropriately normal given the degree of anemia).&nbsp; ACD is normocytic (or slightly microcytic) and normochromic.<p></p>\n<h1>Increased RBC destruction (hemolysis)</h1><br><br><p>Hemolytic anemia is characterized by excessive RBC destruction either intravascularly (in the circulation) or extravascularly (in the RES).&nbsp; Triggers include intrinsic RBC defects (eg, abnormal shape) or external causes (eg, antibody-mediated).</p><br><br><p>In hemolysis, EPO secretion is increased and bone marrow function is intact, resulting in a high reticulocyte count.&nbsp; Laboratory findings reflect high hemoglobin turnover; these include high lactate dehydrogenase (LDH, an enzyme within RBCs) and bilirubin, and decreased haptoglobin (a plasma glycoprotein that binds free hemoglobin in the vasculature).&nbsp; Peripheral blood smear may also reveal various abnormalities specific to the type of anemia (described below).</p><br><br><p>Clinical features of hemolytic anemia (\n                                </p><div class=\"my-8\">\n                                    <img src=\"https://www.uworld.com/media/L111824.png\" alt=\"image 9\" class=\"w-full rounded-lg border border-white border-opacity-20 shadow-lg\">\n                                    <div class=\"text-sm text-center text-white text-opacity-60 mt-2 italic\">image 9</div>\n                                </div>\n                                ) depend on whether the condition is chronic or acute, and whether intravascular or extravascular hemolysis is predominant.&nbsp; Acute presentations are more likely to be symptomatic.<p></p>\n<h2>Intrinsic RBC defects</h2><br><br><p>These conditions are predominantly inherited and entail structural or metabolic abnormalities to the RBC membrane or function that lead to premature destruction.</p><br><br><p><strong>Structural abnormalities</strong></p><br><br><ul class=\"article-body-unordered-list\">\n\t<li><strong>Hereditary spherocytosis</strong> (\n                                <div class=\"my-6\">\n                                    <a href=\"https://www.uworld.com/media/40923.html\" target=\"_blank\" class=\"glass-button w-full py-4 flex items-center justify-center text-white font-bold hover:scale-[1.02] transition-transform\">\n                                        <span class=\"mr-2\">ðŸ“Š</span> View Table: table 10\n                                    </a>\n                                </div>\n                                ):&nbsp; Hereditary spherocytosis is an autosomal disorder caused by an inherited deficiency of RBC scaffolding proteins (eg, spectrin, ankyrin).&nbsp; The sphere-shaped RBCs \n                                <div class=\"my-8\">\n                                    <img src=\"https://www.uworld.com/media/L22861.png\" alt=\"image 10\" class=\"w-full rounded-lg border border-white border-opacity-20 shadow-lg\">\n                                    <div class=\"text-sm text-center text-white text-opacity-60 mt-2 italic\">image 10</div>\n                                </div>\n                                ) are more fragile and get trapped in splenic fenestrations, leading to chronic extravascular hemolysis.&nbsp; The anemia is generally normocytic.&nbsp; Increased MCHC occurs due to membrane loss and RBC dehydration.</li>\n\t<li><strong>Paroxysmal nocturnal hemoglobinuria (PNH)</strong> (\n                                <div class=\"my-6\">\n                                    <a href=\"https://www.uworld.com/media/81696.html\" target=\"_blank\" class=\"glass-button w-full py-4 flex items-center justify-center text-white font-bold hover:scale-[1.02] transition-transform\">\n                                        <span class=\"mr-2\">ðŸ“Š</span> View Table: table 11\n                                    </a>\n                                </div>\n                                ):&nbsp; PNH is caused by complement-mediated hemolysis as result of a mutated phosphatidylinositol glycan class A (<em>PIGA</em>); this results in lack of the glycosylphosphatidylinositol anchor, which connects proteins, including CD55 and CD59, to the cell surface.&nbsp; These proteins normally inhibit the activation of complement on RBCs, but their absence allows the complement membrane attack complex to form and results in hemolysis (\n                                <div class=\"my-8\">\n                                    <img src=\"https://www.uworld.com/media/L24549.png\" alt=\"figure 7\" class=\"w-full rounded-lg border border-white border-opacity-20 shadow-lg\">\n                                    <div class=\"text-sm text-center text-white text-opacity-60 mt-2 italic\">figure 7</div>\n                                </div>\n                                ).&nbsp; Manifestations include hemolytic anemia (including hemoglobinuria, which may be nocturnal); thrombosis occurs at atypical sites (eg, hepatic, portal, or cerebral veins) possibly due to the release of prothrombotic factors from lysed RBCs; and pancytopenia is due to stem cell injury.</li>\n</ul><br><br><p><strong>Metabolic abnormalities</strong></p><br><br><p>The most common abnormality includes a deficiency of <strong>glucose-6-phosphate dehydrogenase (G6PD)</strong>, an enzyme within RBCs that generates NADPH (\n                                </p><div class=\"my-8\">\n                                    <img src=\"https://www.uworld.com/media/L45559.jpg\" alt=\"image 11\" class=\"w-full rounded-lg border border-white border-opacity-20 shadow-lg\">\n                                    <div class=\"text-sm text-center text-white text-opacity-60 mt-2 italic\">image 11</div>\n                                </div>\n                                ), which is required to make glutathione.&nbsp; Without glutathione, oxidative metabolites accumulate in RBCs and denature/precipitate hemoglobin into Heinz bodies (dark red erythrocyte inclusions) (\n                                <div class=\"my-8\">\n                                    <img src=\"https://www.uworld.com/media/L81284.jpg\" alt=\"image 12\" class=\"w-full rounded-lg border border-white border-opacity-20 shadow-lg\">\n                                    <div class=\"text-sm text-center text-white text-opacity-60 mt-2 italic\">image 12</div>\n                                </div>\n                                ), which reduce RBC flexibility and induce damage.&nbsp; G6PD deficiency (passed by X-linked inheritance) is often clinically silent at baseline but can manifest with acute hemolysis in response to oxidative triggers, including infection, medications (eg, trimethoprim-sulfamethoxazole), and certain foods (eg, fava beans) (\n                                <div class=\"my-6\">\n                                    <a href=\"https://www.uworld.com/media/34899.html\" target=\"_blank\" class=\"glass-button w-full py-4 flex items-center justify-center text-white font-bold hover:scale-[1.02] transition-transform\">\n                                        <span class=\"mr-2\">ðŸ“Š</span> View Table: table 12\n                                    </a>\n                                </div>\n                                ).&nbsp; Hemolysis is predominantly extravascular (eg, damaged cells are trapped in the RES); however, intravascular hemolysis also occurs due to oxidative stress.&nbsp; The peripheral smear may reveal evidence of RES pruning of RBCs, including \"bite cells\" (representing removal of precipitated hemoglobin from the erythrocyte membrane by the macrophage) (\n                                <div class=\"my-8\">\n                                    <img src=\"https://www.uworld.com/media/L17211.jpg\" alt=\"image 13\" class=\"w-full rounded-lg border border-white border-opacity-20 shadow-lg\">\n                                    <div class=\"text-sm text-center text-white text-opacity-60 mt-2 italic\">image 13</div>\n                                </div>\n                                ) and blister cells (resealing of the erythrocyte membrane edges after the \"bite\") (\n                                <div class=\"my-8\">\n                                    <img src=\"https://www.uworld.com/media/L81713.png\" alt=\"image 14\" class=\"w-full rounded-lg border border-white border-opacity-20 shadow-lg\">\n                                    <div class=\"text-sm text-center text-white text-opacity-60 mt-2 italic\">image 14</div>\n                                </div>\n                                ).<p></p><br><br><p><strong>Hemoglobinopathies</strong></p><br><br><ul class=\"article-body-unordered-list\">\n\t<li><strong>Sickle cell disease</strong> is caused by a beta-globin gene mutation that results in sickle hemoglobin (HbS) (\n                                <div class=\"my-8\">\n                                    <img src=\"https://www.uworld.com/media/L21119.jpg\" alt=\"image 15\" class=\"w-full rounded-lg border border-white border-opacity-20 shadow-lg\">\n                                    <div class=\"text-sm text-center text-white text-opacity-60 mt-2 italic\">image 15</div>\n                                </div>\n                                , \n                                <div class=\"my-8\">\n                                    <img src=\"https://www.uworld.com/media/L22431.jpg\" alt=\"image 16\" class=\"w-full rounded-lg border border-white border-opacity-20 shadow-lg\">\n                                    <div class=\"text-sm text-center text-white text-opacity-60 mt-2 italic\">image 16</div>\n                                </div>\n                                ), which can lead to vasooclusion in hypoxic conditions and associated complications (eg, splenic infarction, infection, pain crisis).</li>\n\t<li><strong>Thalassemia</strong> is characterized by defective or absent synthesis of â‰¥1 of the 4 alpha- or 2 beta-globin chains.&nbsp; The presentation varies based on number of gene mutations (\n                                <div class=\"my-6\">\n                                    <a href=\"https://www.uworld.com/media/32512.html\" target=\"_blank\" class=\"glass-button w-full py-4 flex items-center justify-center text-white font-bold hover:scale-[1.02] transition-transform\">\n                                        <span class=\"mr-2\">ðŸ“Š</span> View Table: table 13\n                                    </a>\n                                </div>\n                                ); mutations to 3 or 4 globin genes result in utero or fetal death, whereas mild, asymptomatic microcytic anemia is seen with 1 beta-globin chain mutation (beta-thalassemia minor) or 1 or 2 alpha-globin chain mutations (eg, alpha thalassemia minima or minor).&nbsp; Laboratory studies and peripheral smear may demonstrate a disproportionately elevated RBC count and hypochromic, microcytic RBCs and target cells (\n                                <div class=\"my-8\">\n                                    <img src=\"https://www.uworld.com/media/L8232.jpg\" alt=\"image 17\" class=\"w-full rounded-lg border border-white border-opacity-20 shadow-lg\">\n                                    <div class=\"text-sm text-center text-white text-opacity-60 mt-2 italic\">image 17</div>\n                                </div>\n                                ).&nbsp; A Mentzer index (MCV/RBC) &lt;13 helps differentiate alpha and beta thalassemias from IDA (Mentzer index &gt;13).</li>\n</ul>\n<h2>Extrinsic RBC defects</h2><br><br><p>This type of anemia occurs due to immune-mediated causes (eg, autoantibodies, drug-induced) or mechanical trauma (eg, prosthetic valves, fibrin strands or microthrombi in clotting disorders).</p><br><br><p><strong>Immune-mediated:</strong>&nbsp; Immune-mediated anemia can be due to either autoimmune hemolytic anemia (AIHA) or drug-induced autoimmune hemolytic anemia.</p><br><br><ul class=\"article-body-unordered-list\">\n\t<li><strong>AIHA:</strong>&nbsp; This occurs due to the presence of autoantibodies that bind to common RBC antigens (eg, Rh complex) and lead to their destruction.&nbsp; The autoantibodies can either be active in \"warm\" (IgG [eg, normal body temperature]) or \"cold\" (IgM [eg, cold exposure or extremities of the body]) temperatures.&nbsp; Both types are associated with predominant extravascular hemolysis (some intravascular hemolysis may also occur in severe disease), increased MCHC and reticulocytosis.&nbsp; Cold AIHA, unlike warm AIHA, is associated with intravascular agglutination and acrocyanosis (due to the pentameric structure of IgM causing clumping of RBCs) (\n                                <div class=\"my-8\">\n                                    <img src=\"https://www.uworld.com/media/L40313.jpg\" alt=\"figure 8\" class=\"w-full rounded-lg border border-white border-opacity-20 shadow-lg\">\n                                    <div class=\"text-sm text-center text-white text-opacity-60 mt-2 italic\">figure 8</div>\n                                </div>\n                                ).&nbsp; Diagnosis is established by a positive direct antiglobulin (Coombs) test (positive for IgG in warm AIHA, positive for C3 in cold AIHA).&nbsp; The following table describes key differences between warm and cold AIHA (\n                                <div class=\"my-6\">\n                                    <a href=\"https://www.uworld.com/media/79875.html\" target=\"_blank\" class=\"glass-button w-full py-4 flex items-center justify-center text-white font-bold hover:scale-[1.02] transition-transform\">\n                                        <span class=\"mr-2\">ðŸ“Š</span> View Table: table 14\n                                    </a>\n                                </div>\n                                ).</li>\n\t<li><strong>Drug-induced immune-mediated hemolytic anemia</strong> (\n                                <div class=\"my-6\">\n                                    <a href=\"https://www.uworld.com/media/59785.html\" target=\"_blank\" class=\"glass-button w-full py-4 flex items-center justify-center text-white font-bold hover:scale-[1.02] transition-transform\">\n                                        <span class=\"mr-2\">ðŸ“Š</span> View Table: table 15\n                                    </a>\n                                </div>\n                                ):&nbsp; The most common triggers are nonsteroidal anti-inflammatory drugs (eg, diclofenac), penicillins, and anticancer drugs (eg, checkpoint inhibitors).&nbsp; Although medications can trigger hemolysis through a variety of mechanisms (eg, oxidative injury, complement-mediated injury), hemolysis typically occurs when drugs binding to the erythrocyte surface act as a hapten facilitating IgG attachment and subsequent destruction by splenic macrophages (extravascular hemolysis) (\n                                <div class=\"my-6\">\n                                    <a href=\"https://www.uworld.com/media/59785.html\" target=\"_blank\" class=\"glass-button w-full py-4 flex items-center justify-center text-white font-bold hover:scale-[1.02] transition-transform\">\n                                        <span class=\"mr-2\">ðŸ“Š</span> View Table: table 15\n                                    </a>\n                                </div>\n                                ).&nbsp; Severe hemolysis can cause back or abdominal pain due to erythrocytosis in the vertebral bodies, liver, and spleen.&nbsp; The time course is typically hours to a few days after drug administration.&nbsp; The diagnosis of immune-mediated hemolysis is made with a direct antiglobulin (Coombs) test.</li>\n</ul><br><br><p><strong>Mechanical destruction:</strong>&nbsp; These conditions are nonimmune (Coombs-negative) and are caused by mechanical shearing of RBCs, often within the vasculature (intravascular hemolysis).</p><br><br><ul class=\"article-body-unordered-list\">\n\t<li><strong>Microangiopathic hemolytic anemia (MAHA):</strong>&nbsp; This type is characterized by intravascular hemolysis resulting from turbulent blood flow (eg, from vasoconstriction) and shearing of RBCs against microthrombi and fibrin strands within small vessels (eg, arterioles, capillaries).&nbsp; In addition to classic hemolytic findings (eg, high LDH, low haptoglobin), key manifestations include anemia with thrombocytopenia and (schistocytes) on peripheral smear (\n                                <div class=\"my-8\">\n                                    <img src=\"https://www.uworld.com/media/L8254.jpg\" alt=\"image 18\" class=\"w-full rounded-lg border border-white border-opacity-20 shadow-lg\">\n                                    <div class=\"text-sm text-center text-white text-opacity-60 mt-2 italic\">image 18</div>\n                                </div>\n                                ).&nbsp; MAHA can result from thrombotic microangiopathies, including:<br><br>\t<ul class=\"article-body-unordered-list\">\n\t\t<li><strong>Hemolytic uremic syndrome</strong> (eg, from Shiga toxinâ€“producing <em>Escherichia coli</em>) (\n                                <div class=\"my-6\">\n                                    <a href=\"https://www.uworld.com/media/36652.html\" target=\"_blank\" class=\"glass-button w-full py-4 flex items-center justify-center text-white font-bold hover:scale-[1.02] transition-transform\">\n                                        <span class=\"mr-2\">ðŸ“Š</span> View Table: table 17\n                                    </a>\n                                </div>\n                                )</li>\n\t\t<li><strong>Thrombotic thrombocytopenic purpura</strong>, characterized by accumulation of large multimers of von Willebrand factor (eg, from deficiency of the cleaving enzyme ADAMTS13) causing platelet aggregation and microthrombi</li>\n\t\t<li><strong>Disseminated intravascular coagulation (DIC)</strong> (\n                                <div class=\"my-8\">\n                                    <img src=\"https://www.uworld.com/media/L50403.jpg\" alt=\"figure 9\" class=\"w-full rounded-lg border border-white border-opacity-20 shadow-lg\">\n                                    <div class=\"text-sm text-center text-white text-opacity-60 mt-2 italic\">figure 9</div>\n                                </div>\n                                ), seen in the setting of trauma, sepsis, malignancy, or pregnancy; it is caused by global activation of the coagulation cascade manifesting with concomitant bleeding and microthrombi.</li>\n\t</ul>\n\t</li>\n\t<li>Other conditions associated with MAHA include severe hypertension, which can precipitate endothelial damage and incite microthrombi formation, and prosthetic valves, with MAHA typically seen only with dysfunctional mechanical prosthetic valve (eg, paravalvular regurgitation).</li>\n</ul>\n<h1>Systematic approach to evaluation</h1><br><br><p>The evaluation of anemia requires a logical and systematic process that integrates clinical findings and symptoms with laboratory tests to progressively narrow the differential diagnosis (\n                                </p><div class=\"my-8\">\n                                    <img src=\"https://www.uworld.com/media/L29465.png\" alt=\"figure 10\" class=\"w-full rounded-lg border border-white border-opacity-20 shadow-lg\">\n                                    <div class=\"text-sm text-center text-white text-opacity-60 mt-2 italic\">figure 10</div>\n                                </div>\n                                ).&nbsp; The patient's history, risk factors, and physical examination, in combination with CBC, inform the need for targeted, additional testing.&nbsp; One approach (out of several possible ones) is presented here.<p></p>\n<h2>Step 1:&nbsp; Assess patient symptoms and history</h2><br><br><ul class=\"article-body-unordered-list\">\n\t<li><strong>Timing of symptoms:</strong>&nbsp; Sudden, prominent symptoms (eg, tachycardia, syncope, shock) suggest acute blood loss (eg, hemorrhage, hemolysis), whereas chronic causes may be asymptomatic and have an insidious presentation.</li>\n\t<li><strong>Associated findings:</strong>&nbsp; These may point toward hemolysis (eg, jaundice, abdominal pain, purpura, splenomegaly, hemoglobinuria), nutritional deficiencies (eg, neuropathy, hair loss, pica), or malignancy (eg, malaise, night sweats).</li>\n\t<li><strong>Family history and lifestyle/social factors:</strong>&nbsp; These can identify likely hereditary disorders; in addition, historical intake covering regularity and heaviness of menstrual cycle, quality and type of diet, and use of substances (eg, alcohol, tobacco) can be useful.</li>\n\t<li><strong>Other abnormalities in CBC:</strong>&nbsp; The presence of â‰¥2 cytopenias (eg, leukopenia, thrombocytopenia) suggests a possible bone marrow disorder, whereas marked leukocytosis may indicate infection or malignancy.</li>\n\t<li><strong>Presence of comorbidities:</strong>&nbsp; Certain chronic conditions (eg, chronic kidney disease, autoimmune disorders) may increase the risk for anemia of chronic disease.</li>\n</ul>\n<h2>Step 2:&nbsp; Mean corpuscular volume</h2><br><br><ul class=\"article-body-unordered-list\">\n\t<li><strong>Microcytosis (MCV &lt;80 Î¼m</strong><font size=\"2\"><sup><strong>3</strong></sup></font><strong>):</strong>&nbsp; This finding suggests deficient hemoglobin synthesis, as seen in IDA and thalassemia; very low MCV suggests thalassemia or advanced IDA (eg, hemoglobin &lt;10 g/dL).&nbsp; However, ACD may also be associated with mild microcytosis.&nbsp; Therefore, the next step in mild microcytic anemia is to obtain iron studies (serum iron, ferritin, transferrin, transferrin saturation), which can differentiate between IDA, ACD, and thalassemia (\n                                <div class=\"my-6\">\n                                    <a href=\"https://www.uworld.com/media/35096.html\" target=\"_blank\" class=\"glass-button w-full py-4 flex items-center justify-center text-white font-bold hover:scale-[1.02] transition-transform\">\n                                        <span class=\"mr-2\">ðŸ“Š</span> View Table: table 18\n                                    </a>\n                                </div>\n                                ).&nbsp; Normal iron studies with an elevated RBC count and microcytosis suggest thalassemia; additional hemoglobin-specific testing should be considered in this setting (eg, globin gene studies, hemoglobin electrophoresis).&nbsp; Note that in children age &lt;2 with mild microcytic anemia (hemoglobin &lt;11 g/dL) and a dietary history suggestive of iron deficiency, iron studies are not needed; response to empiric iron therapy confirms the diagnosis of IDA.</li>\n\t<li><strong>Normocytic anemia:</strong>&nbsp; This category is most common and also most nonspecific because it can be seen in the early stages of a variety of disorders (eg, early nutritional deficiencies, hemolysis, IDA, ACD, hypothyroidism), or may represent combined disorders (eg, combined IDA and vitamin B<font size=\"2\"><sub>12</sub></font> deficiency).&nbsp; Therefore, the next step is to assess bone marrow function with the reticulocyte count and assess for early IDA with iron studies.&nbsp; The reticulocyte count guides further testing (eg, hemolysis studies or testing for underlying lymphoproliferative disorders [eg, bone marrow studies]).</li>\n\t<li><strong>Macrocytic anemia:</strong>&nbsp; This is most commonly caused by inadequate cell division during erythropoiesis, as seen in vitamin B<font size=\"2\"><sub>12</sub></font> or folate deficiency (eg, accompanied by a low reticulocyte count).&nbsp; Mild macrocytosis can also be seen with hemolysis due to increased reticulocyte production (eg, accompanied by increased reticulocyte count and RDW).&nbsp; Other causes include myelodysplasia, hypothyroidism, aplastic anemia, excessive alcohol use, and medications.&nbsp; The next step is generally to obtain serum B<font size=\"2\"><sub>12</sub></font> and folate levels, reticulocyte count, and a TSH.&nbsp; If these are negative, a peripheral blood smear should be assessed.</li>\n</ul>\n<h2>Step 3:&nbsp; Reticulocyte count</h2><br><br><p>The reticulocyte count indicates bone marrow activity; it should be corrected for the degree of anemia (because the count may be \"normal\" but is actually inadequate given the degree of anemia).&nbsp; This \"corrected\" reticulocyte count may sometimes be reported as the reticulocyte index.</p><br><br><ul class=\"article-body-unordered-list\">\n\t<li><strong>Low reticulocyte count</strong> suggests possible nutritional deficiency (eg, advanced IDA, vitamin B<font size=\"2\"><sub>12</sub></font>, folate, or copper), impairment of renal function (eg, insufficient EPO stimulus), or primary bone marrow disorder.&nbsp; The reticulocyte count can also be inappropriately low in the setting of acute bleeding (eg, &lt;48 hr).&nbsp; If the cause is not apparent, iron studies and testing of renal function should be obtained.&nbsp; The presence of other cytopenias should prompt possible bone marrow biopsy.</li>\n\t<li><strong>High reticulocyte count</strong> indicates appropriate marrow response, which can be seen during treatment of nutritional deficiencies, post-acute hemorrhage, and hemolysis.&nbsp; Testing for hemolysis (eg, LDH, haptoglobin, peripheral smear) should be performed if the cause is unknown.</li>\n</ul>\n<h2>Special tests based on clinical suspicion</h2><br><br><p>Based on results of initial testing and clinical presentation, additional specialized testing may be performed based on clinical suspicion:</p><br><br><ul class=\"article-body-unordered-list\">\n\t<li><strong>Bone marrow biopsy</strong> is indicated if aplastic anemia, myelodysplastic syndromes, or unexplained pancytopenia is suspected; this test directly visualizes cells in the bone marrow and can identify dysplasia or hypocellularity.</li>\n\t<li><strong>G6PD assay</strong> is appropriate in cases where oxidative hemolysis is suspected (eg, patient with hemolysis following classic exposure).</li>\n\t<li><strong>Coagulation studies and hemolysis laboratory testing</strong> may be useful in cases of suspected DIC or other thrombotic microangiopathies; testing includes LDH, haptoglobin, bilirubin.</li>\n\t<li><strong>Peripheral blood smear</strong> is useful for identifying specific RBC abnormalities (eg, spherocytes, hypochromia), ineffective RES function, or evidence of RBC destruction.&nbsp; This table summarizes common RBC abnormalities seen on the peripheral smear (\n                                <div class=\"my-6\">\n                                    <a href=\"https://www.uworld.com/media/120035.html\" target=\"_blank\" class=\"glass-button w-full py-4 flex items-center justify-center text-white font-bold hover:scale-[1.02] transition-transform\">\n                                        <span class=\"mr-2\">ðŸ“Š</span> View Table: table 19\n                                    </a>\n                                </div>\n                                ).</li>\n</ul><br><br><p>In practice, some of these steps may be performed simultaneously based on a synthesis of the historical and laboratory data.</p>\n<h1>Summary</h1><br><br><p>Anemia is a multifactorial condition that can be caused by blood loss (acute or chronic), decreased red blood cell production (eg, nutritional deficiencies, bone marrow dysfunction), or increased red blood cell destruction (immune-mediated or mechanical).&nbsp; Diagnosis of anemia requires an organized, systematic approach integrating patient symptoms with laboratory testing.&nbsp; Parameters such as the mean corpuscular volume and reticulocyte count can assist in narrowing the differential diagnosis and inform next steps (eg, iron studies, hemolysis laboratory testing, vitamin B<font size=\"2\"><sub>12</sub></font> levels, bone marrow biopsy).</p>\n</div>\n\n            "
}